Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Fish and Richardson
Federal Trade Commission
Harvard Business School
Baxter

Generated: August 21, 2019

DrugPatentWatch Database Preview

Patent: 5,610,054

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,610,054
Title: Enzymatic RNA molecule targeted against Hepatitis C virus
Abstract:An enzymatic RNA molecule which specifically cleaves RNA of a hepatitis C virus.
Inventor(s): Draper; Kenneth G. (Boulder, CO)
Assignee: Ribozyme Pharmaceuticals, Inc. (Boulder, CO)
Application Number:08/182,968
Patent Claims:see list of patent claims

Details for Patent 5,610,054

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2014-03-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2014-03-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2014-03-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 5,610,054

Country Patent Number Publication Date
United States of America 2001006801 Jul 05, 2001
United States of America 2002013458 Jan 31, 2002
United States of America 2002082225 Jun 27, 2002
United States of America 2002192685 Dec 19, 2002
United States of America 2002193579 Dec 19, 2002
United States of America 2002197684 Dec 26, 2002
United States of America 2003003469 Jan 02, 2003
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Chubb
Boehringer Ingelheim
Accenture
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.